What is the best approach to preventing oxygen toxicity during prolonged oxygen therapy?

• A. Provide oxygen only when cyanosis is visible.
• B. Administer high-concentration oxygen at all times.
• C. Use blending to maintain targeted SpO2 and monitor SpO2 continuously.
• D. Discontinue oxygen as soon as symptoms subside.

Answer: (C)

The key idea is titrating oxygen to a safe, specific range and watching oxygen saturation continuously so you can adjust promptly. When you blend to achieve a target SpO2, you’re not just blasting in high oxygen; you’re mixing oxygen with room air to hit a predetermined saturation window. This keeps tissue oxygenation adequate while limiting exposure to high oxygen levels that can cause oxidative stress over time.

Continuous SpO2 monitoring lets you see in real time how a patient responds to the oxygen mix, so you can fine-tune the FiO2 as the situation changes. This approach reduces the risk of oxygen toxicity that comes from prolonged high FiO2, helps prevent episodes of hypoxemia, and is especially important in neonates and children who are more vulnerable to oxygen-related complications like retinopathy of prematurity or inflammatory lung injury.

Relying on symptoms such as cyanosis to guide therapy is unreliable because changes in oxygenation can occur before visible signs appear, and waiting for symptoms can lead to periods of unnoticed hypoxemia or hyperoxemia. Keeping oxygen therapy as a controlled, continuously monitored process ensures safety and effectiveness throughout prolonged treatment. Discontinuing oxygen as soon as symptoms subside or maintaining a fixed high concentration without monitoring are both risky because they ignore the patient’s evolving needs and the potential for fluctuating oxygen levels.